phenomenon
viral
interfer
first
describ
nearli
year
ago
hoskin
describ
protect
action
neurotrop
yellow
fever
viru
viserotrop
strain
viru
monkey
although
viral
interfer
investig
underli
mechan
discov
isaac
lindemann
work
nation
institut
medic
research
london
uk
isol
biolog
activ
substanc
virallyinfect
chicken
cell
cultur
transfer
fresh
chicken
cell
cultur
produc
protect
antivir
effect
isaac
lindemann
word
interferon
ifn
coin
substanc
discoveri
arous
consider
scientif
medic
interest
sinc
antibiot
wide
avail
control
bacteri
infect
stark
contrast
viral
diseas
influenza
measl
polio
smallpox
virtual
untreat
interest
heighten
mani
subsequ
studi
demonstr
ifn
could
produc
human
cell
activ
broad
spectrum
virus
see
schlesing
earli
review
time
ifn
hail
media
wonder
drug
soon
becam
clear
ifn
produc
natur
small
quantifi
extravag
claim
immedi
confirm
fact
low
product
ifn
bedevil
attempt
character
molecularli
evalu
clinic
mani
year
follow
discoveri
although
protein
natur
ifn
recogn
earli
stage
develop
see
fant
earli
review
follow
introduct
largescal
product
method
cantel
hirvonen
simultan
develop
effici
purif
procedur
knight
rubinstein
et
al
suffici
amount
partial
pure
ifn
protein
becam
avail
character
clinic
use
gradual
becam
appar
ifn
singl
protein
like
differ
type
ifn
molecul
howev
despit
progress
area
purif
initi
character
sequenc
ntermin
polypeptid
ifn
protein
defi
full
character
advent
recombin
dna
rdna
technolog
late
technolog
spur
pharmaceut
industri
desir
produc
pharmacolog
activ
protein
cheapli
reveal
one
type
human
ifn
design
ifncx
mixtur
sever
close
relat
protein
term
subtyp
express
distinct
chromosom
gene
second
third
type
ifn
design
ifni
respect
subsequ
clone
taniguchi
et
al
gray
et
al
unlik
singl
protein
speci
molecularli
relat
ifn
subtyp
antigen
distinct
wherea
ifni
molecularli
antigen
distinct
either
ifncx
subtyp
reason
ifni
consid
separ
elsewher
volum
final
fourth
type
ifn
antigen
distinct
molecularli
relat
recent
clone
character
rather
untyp
new
ifn
type
design
ifn
omega
adolf
gene
subtyp
tandemli
arrang
short
arm
chromosom
transient
express
follow
induct
varieti
exogen
stimuli
includ
virus
protein
synthes
respect
mrna
rel
short
period
follow
gene
activ
secret
act
via
specif
cell
surfac
receptor
cell
earli
studi
character
ifn
receptor
indic
like
share
common
receptor
compar
recent
receptor
clone
uz
et
al
novick
et
al
ifn
action
initi
activ
receptor
cytoplasm
signal
transduct
pathway
well
character
receptor
manifest
follow
express
number
ifnspecif
induc
gene
induct
antivir
state
depend
protein
synthesi
may
view
one
mani
activ
attribut
ifn
gener
activ
includ
inhibit
cell
prolifer
immunomodul
see
pestka
et
al
review
two
type
lfn
defin
basi
capac
antivir
activ
withstand
acidif
ph
term
type
ifn
acidst
ifn
type
ii
ifn
acidlabil
ifn
type
ifn
includ
ifn
produc
viral
infect
leukocyt
altern
known
leukocyt
ifn
ifn
produc
viral
infect
human
diploid
fibroblast
altern
known
fibroblast
ifn
type
ii
ifn
produc
antigen
mitogen
stimul
human
peripher
blood
mononuclear
cell
pbmc
often
refer
immun
ifn
stewart
antigen
differ
describ
leukocyt
fibroblast
ifn
put
molecular
basi
knowledg
respect
ntermin
amino
acid
sequenc
becam
avail
allen
fant
knight
et
al
levi
et
al
zoon
et
al
time
intern
nomenclatur
committe
stewart
et
al
review
grow
evid
exist
distinct
molecular
form
ifn
introduc
greek
alphabet
system
appli
known
antigen
distinct
type
ifn
leukocyt
ifn
design
ifn
fibroblast
ifn
design
immun
ifn
becam
ifni
howev
complic
immedi
aros
reveal
follow
clone
sever
differ
leukocyt
ifn
complementari
dna
cdna
brack
et
al
goeddel
et
al
streuli
et
al
leukocyt
ifn
heterogen
contain
mani
differ
molecularli
antigen
relat
speci
commonli
refer
subtyp
research
group
hoffmannla
roch
label
subtyp
produc
e
coli
ra
etc
eving
et
al
rehberg
et
al
distinguish
natur
compon
leukocyt
ifn
biogen
group
label
recombin
subtyp
etc
regrett
without
appropri
alphabeticalnumer
correspond
exampl
k
howev
numer
system
prevail
ifn
prepar
mixtur
ifn
subtyp
eg
leukocyt
ifn
lymphoblastoid
ifn
often
design
ifnon
later
clone
cdna
encod
protein
capon
et
al
hauptmann
swetli
initi
led
name
new
ifn
ifno
subclass
ii
earliercharacter
subtyp
reclassifi
ifntx
subclass
larg
unwieldi
nomenclatur
system
supersed
renam
ifn
ii
gener
accept
find
antigen
distinct
ifn
ifni
protein
thu
qualifi
separ
type
ifn
adolf
fortun
nomenclatur
ifni
remain
straightforward
sinc
one
protein
speci
least
human
derynck
et
al
taniguchi
et
al
initi
clone
ifno
cdna
plethora
report
clone
new
sometim
distinct
genom
edna
clone
fairli
dispar
nomenclatur
arisen
diaz
allen
therefor
undertook
consider
task
compil
ifn
gene
genom
cdna
clone
literatur
introduc
arabicalphabet
system
name
ifn
gene
enabl
distinct
ifn
protein
thu
ifnoc
gene
becam
ifna
gene
addit
numer
denot
subtyp
ie
etc
tabl
ifn
gene
becam
ifnb
sinc
one
gene
human
refer
ifnb
gene
w
use
henc
tabl
besid
gene
capabl
express
translat
ifn
protein
number
pseudogen
unabl
give
rise
ifn
protein
new
nomenclatur
system
design
p
eg
simpli
pseudogen
clearli
ifnlik
definit
includ
one
ifna
ifnb
ifnw
gene
famili
tabl
ifn
genom
edna
clone
design
varieti
way
illustr
tabl
pseudogen
nontranslat
clone
normal
prefix
greek
purpos
chapter
reduc
complex
name
ifn
clone
protein
nomenclatur
system
adopt
weissmann
colleagu
adher
etc
number
structur
local
human
nonallel
ifna
gene
one
pseudogen
tabl
addit
four
nonallel
pseudogen
possibl
also
belong
ifna
gene
famili
probabl
allel
variant
certain
ifna
gene
eg
also
known
exist
goeddel
et
al
dworkinrastl
et
al
emanuel
pestka
extens
famili
ifna
gene
tandemli
arrang
shortarm
chromosom
span
region
approxim
kb
owerbach
et
al
show
et
al
slate
et
al
ullrich
et
al
ifnb
gene
ifnw
genepseudogen
famili
also
locat
region
chromosom
meager
et
al
b
owerbach
et
al
henri
et
al
capon
etal
high
degre
homolog
among
ifna
gene
show
much
less
homolog
either
ifnb
ifnw
gene
nevertheless
ifn
gene
share
common
featur
intronless
taniguchi
et
al
goeddel
et
al
houghton
et
al
capon
et
al
suggest
ancient
origin
common
ancestr
gene
propos
primordi
ifn
gene
aros
million
year
ago
first
split
occur
around
million
year
ago
yield
first
ifna
ifnb
gene
wilson
et
al
sinc
ifna
gene
evolv
duplic
mani
time
give
rise
multipl
ifna
gene
found
presentday
anim
man
mijita
hayashida
gillespi
carter
around
million
year
ago
ifna
gene
appear
diverg
suffici
main
group
give
rise
ifnw
gene
famili
present
mammal
except
mice
dog
himmler
et
al
robert
et
al
clear
characterist
ifna
ifnw
gene
enabl
numer
redupl
event
occur
comparison
nonexist
limit
mammal
one
ifnb
gene
eg
bovin
wilson
et
al
redupl
ifnb
gene
ohlsson
et
al
appar
gene
convers
result
mismatch
repair
unequ
crossov
contribut
significantli
creation
distinct
highli
homolog
nonallel
ifna
ifnw
gene
de
maeyer
de
maeyerguignard
case
code
noncod
region
diverg
case
code
region
remain
ident
although
flank
region
diverg
todokoro
et
al
structur
ifna
ifnb
ifnw
gene
similar
gene
regulatori
promot
region
upstream
transcript
start
cap
site
ifnal
ifna
ifnap
ifnoq
ifno
h
lelfd
ifnoq
ifna
ifn
adapt
modifi
diaz
allen
allen
diaz
see
specif
refer
genom
clone
cdna
reproduc
permiss
mari
ann
liebert
inc
new
york
usa
code
region
contain
nucleotid
sequenc
encod
signal
polypeptid
mainli
hydrophob
amino
acid
typic
secret
protein
consecut
sequenc
encod
matur
ifn
protein
follow
flank
noncod
region
vari
length
base
pair
bp
figur
derynck
etal
derynck
etal
nagata
et
al
streuli
et
al
taniguchi
et
al
degrav
etal
goeddel
etal
gross
et
al
lawn
et
al
b
gren
et
al
capon
et
al
henco
et
al
flank
region
contain
tata
hog
box
delin
boundari
upstream
promot
approxim
bp
cap
site
farther
upstream
found
number
ofhexamer
repeat
sequenc
gaaann
n
base
dimer
multimer
form
act
bind
site
nuclear
transcript
factor
repressor
molecul
fujita
et
al
ryal
et
al
area
cover
detail
section
induc
transcript
control
flank
region
vari
length
contain
sever
polyadenyl
site
thu
give
rise
mrna
differ
length
mantei
weissmann
henco
et
al
contain
aboveaverag
number
sequenc
motif
atta
ttatttat
sequenc
common
howev
mani
cytokin
gene
gene
protooncogen
induc
transient
express
propos
sequenc
contribut
rel
instabl
short
halfliv
ifn
cytokin
mrna
caput
et
al
shaw
kamen
ifn
gene
normal
silent
thu
requir
sort
stimulu
induc
express
wide
rang
induc
includ
virus
bacteria
mycoplasma
endotoxin
doublestrand
polynucleotid
rna
dsrna
cytokin
shown
effici
activ
transcript
ifn
gene
stewart
de
maeyer
de
maeyerguignard
induc
gener
potenti
induc
express
ifna
ifnb
ifnw
gene
howev
appear
celland
inducerspecif
select
govern
type
number
ifn
gene
express
instanc
viral
induc
human
diploid
fibroblast
produc
mainli
minor
amount
ifn
havel
et
al
wherea
viral
induc
pbmc
produc
mainli
ifna
plu
minor
amount
ifn
cantel
hirvonen
adolf
et
al
extent
confirm
mrna
level
shuttleworth
et
al
hiscott
et
al
differ
also
report
proport
individu
subtyp
produc
differ
cell
type
goren
et
al
finter
greenway
et
al
suggest
ifna
gene
may
differenti
express
howev
way
differenti
express
regul
present
understood
transcript
control
ifna
gene
resid
flank
region
upstream
cap
site
nucleotid
delet
outsid
cap
site
littl
impact
transcript
control
delet
farther
elimin
induct
indic
region
contain
promot
regulatori
element
ragg
weissmann
weidl
weissmann
delin
purinerich
nucleotid
tract
contain
hexamer
repeat
gaaann
gaaa
gc
tc
appear
necessari
induc
transcript
term
virusregul
element
vre
ryal
et
al
similar
studi
involv
delet
carri
ifnb
gene
found
sequenc
contain
regulatori
element
requir
induct
virus
dsrna
minimum
vre
local
respect
cap
site
goodbourn
et
al
goodbourn
maniati
contain
two
posit
virusinduc
element
term
posit
regulatori
domain
prdi
prdii
neg
regulatori
domain
nrd
figur
fujita
et
al
fan
maniati
whittemor
maniati
nourbakhsh
et
al
addit
hexamer
repeat
sequenc
gaaann
also
present
ifna
gene
span
contain
variant
prdi
sequenc
two
regulatori
element
prdiii
prdw
identifi
requir
function
vre
ifnb
gene
express
mous
l
cell
dinter
hauser
du
maniati
prdi
prdiii
act
bind
site
nuclear
transcript
factor
design
interferon
regulatori
factorl
whose
express
transient
increas
viru
infect
appear
mediat
activ
transcript
ifnb
gene
fujita
et
al
harada
et
al
xanthoudaki
et
al
second
virusinduc
factor
design
interferon
regulatori
also
bind
prdi
suppress
rather
activ
transcript
harada
et
al
harada
et
al
prdii
bind
site
nuclear
transcript
factor
clark
hay
fujita
et
al
hiscott
et
al
lenardo
et
al
visvanathan
goodbourn
interact
major
groov
dna
thano
maniati
addit
anoth
protein
highmobl
group
yl
also
bind
prdii
interact
minor
groov
dna
thano
maniati
factor
appear
necessari
viru
induct
ifnb
gene
promot
prdiv
contain
bind
site
protein
camp
respons
element
bind
protein
atfcreb
famili
transcript
factor
du
maniati
viral
induct
ifnb
gene
thought
occur
follow
activ
preexist
nftcb
de
novo
synthesi
nuclear
transcript
factor
bind
tandemli
arrang
prdi
prdii
act
cooper
initiateactiv
transcript
leblanc
et
al
lenardo
et
al
visvanathan
goodbourn
fujita
et
al
watanab
et
al
report
construct
contain
prdi
support
simian
viru
enhanc
gaaagt
contain
function
equival
dimer
prdi
nif
et
al
activ
viru
also
overexpress
macdonald
et
al
howev
cell
line
overexpress
led
poor
induct
ifnb
ifna
gene
harada
et
al
fujita
et
al
none
macdonald
et
al
rei
et
al
attribut
repress
effect
homologu
also
bind
prdi
harada
et
al
undifferenti
murin
embryon
carcinoma
stem
cell
line
refractori
viral
induct
oflfnb
ifna
gene
express
neither
overexpress
introduc
construct
lead
activ
endogen
ifn
gene
activ
report
plasmid
ifnb
promot
harada
et
al
addit
cell
line
perman
transform
antisens
express
plasmid
exhibit
strongli
reduc
ifnb
gene
induc
nevertheless
could
restor
transient
transform
irfloverproduc
express
plasmid
rei
et
al
howev
role
virusinduc
activ
ifnb
promot
remain
controversi
whitesid
et
al
pine
et
al
ruffner
colleagu
shown
murin
embryon
stem
cell
devoid
gene
allel
viral
induct
ifnb
slightli
higher
control
differenti
stem
cell
differenti
cell
suggest
high
level
may
elicit
enhanc
induct
ifnb
certain
circumst
essenti
viral
induct
cultur
mous
fibroblast
devoid
ifnb
induct
synthet
dsrna
molecul
poli
poli
c
absent
wherea
induct
newcastl
diseas
viru
ndv
normal
matsuyama
et
al
howev
ifn
induct
vivo
either
viru
dsrna
found
unimpair
mice
indic
essenti
also
becom
clear
recent
prdi
site
bind
factor
may
import
regul
ifnb
gene
activ
whitesid
et
al
keller
maniati
contrast
target
disrupt
gene
yield
mous
fibroblast
defici
repressor
found
lead
upregul
induct
ifnb
follow
ndv
infect
matsuyama
et
al
suggest
neg
regul
repress
ifnb
gene
induct
induct
gene
appear
regul
differ
ifnb
gene
bound
poorli
equival
prdi
site
promot
promot
also
lack
nfcb
site
figur
macdonald
et
al
gene
vre
contain
hexamer
repeat
nucleotid
sequenc
gaaatg
design
tgsequenc
macdonald
et
al
appear
mediat
viru
induc
support
enhanc
respond
nif
et
al
howev
report
overexpress
induc
ifna
gene
least
special
circumst
harada
et
al
au
et
al
ifnw
gene
like
ifna
ifnb
gene
viru
induc
structur
featur
promot
region
similar
ifnab
promot
figur
particular
hexamer
repeat
unit
present
organ
differ
present
ifnab
gene
hansen
et
al
robert
et
al
howev
regul
transcript
ifnw
gene
studi
detail
ifn
x
subtyp
secret
protein
transcrib
mrna
precursor
protein
preifn
x
contain
ntermin
signal
polypeptid
mainli
hydrophob
amino
acid
figur
signal
polypeptid
cleav
matur
ifn
x
molecul
secret
cell
cerna
sequenc
matur
ifn
x
subtyp
predict
contain
amino
acid
except
ifn
amino
acid
nagata
et
al
goeddel
et
al
lawn
et
al
b
gren
et
al
calcul
molecular
mass
recombin
ifn
x
subtyp
approxim
kda
although
appar
molecular
mass
leukocytederiv
ifn
x
subtyp
sodium
dodecyl
sulphat
sd
polyacrylamid
gel
vari
kda
possibl
owe
variabl
process
ctermin
amino
acid
le
w
et
al
posttransl
modif
amino
acid
sequenc
ifn
x
subtyp
highli
relat
complet
ident
amino
acid
posit
langer
pestka
de
maeyer
de
maeyerguignard
illustr
figur
amino
acid
sequenc
subtyp
compar
ideal
consensu
sequenc
mani
posit
amino
acid
differ
subtyp
subtyp
conserv
substitut
interestingli
ifn
x
subtyp
contain
four
cystein
residu
whose
posit
highli
conserv
figur
four
cystein
form
disulfid
bridg
induc
fold
ifn
x
molecul
figur
whose
integr
essenti
biolog
activ
morehead
et
al
ifn
x
subtyp
predict
contain
high
proport
xhelic
region
fold
form
globular
protein
zoon
wetzel
yet
prove
possibl
appli
xray
crystallograph
techniqu
ifn
x
subtyp
human
threedimension
crystal
structur
recombin
mous
ifn
approxim
relat
amino
acid
sequenc
human
counterpart
solv
senda
et
al
reveal
mous
ifn
structur
consist
five
xhelic
fold
compact
xhelic
bundl
figur
compar
sequenc
analysi
predict
mammalian
ifn
x
ifn
protein
five
xhelic
domain
conserv
korn
et
al
horisberg
di
marco
thu
show
similar
mani
cytokin
also
xhelic
bundl
structur
bazan
one
except
ifn
x
subtyp
contain
recognit
site
asnxserthr
nlink
glycosyl
henco
et
al
ifn
contain
two
site
figur
nevertheless
olink
glycosyl
may
possibl
ifn
x
subtyp
exampl
found
natur
ifn
purifi
human
leukocyt
ifn
contain
disaccharid
galactosylnacetylgalactosamin
olinkag
adolf
et
al
howev
sinc
ifn
ifn
x
subtyp
theonin
posit
may
repres
oglycosyl
ifn
x
protein
figur
compris
matur
ifn
protein
derynck
et
al
taniguchi
et
al
houghton
et
al
although
ifn
length
major
ifna
subtyp
show
approxim
amino
acid
sequenc
related
figur
antigen
distinct
ifn
protein
lack
ntermin
residu
present
ifna
subtyp
contain
three
cystein
posit
latter
two
correspond
disulfid
bond
pair
ifna
subtyp
replac
serin
result
loss
biolog
activ
wherea
serin
substitut
mark
et
al
shepard
et
al
mention
previous
basi
threedimension
structur
recombin
mous
ifn
figur
human
ifn
predict
contain
five
ahelic
fold
ahel
bundl
structur
senda
et
al
human
ifn
one
potenti
nglycosyl
site
taniguchi
et
al
nlink
oligosaccharid
primarili
biantennari
complextyp
known
attach
site
natur
hosoi
et
al
howev
may
vari
consider
depend
produc
cell
type
utsumi
et
al
cdna
sequenc
data
predict
preifnm
contain
amino
acid
ntermin
compris
signal
sequenc
remain
matur
ifnm
protein
capon
et
al
hauptmann
swetli
amino
acid
sequenc
ifnm
therefor
six
residu
longer
cterminu
ifnr
ifn
protein
howev
found
natur
ifnm
heterogen
nterminu
owe
variabl
cleavag
preifnm
matur
ifnm
molecul
carri
two
addit
ntermin
amino
acid
adolf
shirono
et
al
approxim
relat
ifncx
subtyp
sequenc
relat
ifn
figur
antigen
distinct
ifn
ifn
adolf
nevertheless
four
cystein
occur
notion
posit
ifn
subtyp
like
ifnm
similar
cxhelic
bundl
structur
predict
ifncx
ifn
protein
senda
et
al
ifnm
one
potenti
site
nlink
glycosyl
natur
ifnm
demonstr
glycoprotein
biantennari
complex
oligosaccharid
contain
neuramin
acid
attach
site
adolf
adolf
et
al
b
type
ifn
andm
produc
varieti
normal
cell
type
respond
extracellular
intracellular
stimuli
stewart
ifn
mixtur
subtyp
ifnm
may
produc
togeth
follow
viral
infect
null
lymphocyt
monocytesmacrophag
cantel
hirvonen
adolf
proport
subtyp
may
vari
accord
type
viru
use
induc
hiscott
finter
howev
product
ifn
usual
restrict
doublestrand
polynucleotid
eg
polyinosin
polycytidyl
acid
well
establish
biolog
activ
ifn
mostli
depend
upon
protein
synthesi
select
subset
protein
mediat
individu
activ
antivir
antiprolif
immunomodulatori
activ
ascrib
ifn
review
pestka
et
al
de
maeyer
de
maeyerguignard
protein
mechan
involv
activ
describ
virallyinduc
normal
fibroblast
tissu
cell
type
eg
epitheli
cell
meager
et
al
stewart
case
amount
ifn
secret
depend
dose
induc
besid
normal
cell
rang
transform
tumorderiv
cell
line
known
ifn
produc
eg
human
osteosarcoma
cell
line
meager
et
al
namalwa
blymphoblastoid
cell
line
phillip
et
al
gener
speak
adher
fibroblast
cell
line
produc
mainli
ifn
minor
quantiti
ifn
havel
et
al
wherea
nonadher
myeloid
lymphoid
cell
line
produc
mainli
ifnc
small
amount
cantel
hirvonen
shuttleworth
et
al
zoon
et
al
actual
product
ifn
last
matter
hour
follow
induct
due
ifn
mrna
instabl
rapid
shutoff
ifn
gene
transcript
caput
et
al
shaw
kamen
condit
ifn
mrna
stabil
increas
eg
block
protein
rna
synthesi
follow
induct
ifn
product
shown
superinduc
block
protein
synthesi
remov
meager
et
al
stewart
despit
vast
number
virus
differ
replic
strategi
appear
mani
virus
counter
rel
ifninduc
antivir
protein
samuel
one
bestcharacter
famili
enzym
collect
known
synthetas
presenc
dsrna
often
intermedi
viral
rna
synthesi
catalys
format
unusu
oligonucleotid
ppp
p
na
turn
activ
ifninduc
latent
endonucleas
rnase
l
william
kerr
wreschner
et
al
ghosh
et
al
hovanessian
lengyel
zhou
et
al
activ
rnase
l
degrad
viral
cellular
mrna
therefor
inhibit
viral
protein
synthesi
small
rna
virus
picornavirida
eg
mengo
viru
murin
encephalomyocard
viru
emcv
whose
replic
cytoplasm
inhibit
induct
synthetas
lengyel
rice
et
al
chebath
et
al
kumar
et
al
import
ifninduc
antivir
protein
dsrnadepend
protein
kinas
design
pkr
activ
form
phosphoryl
peptid
initi
factor
involv
polyribosom
translat
mrna
miyamoto
samuel
gupta
et
al
samuel
phosphoryl
inact
thu
viral
protein
synthesi
inhibit
inhibit
associ
loss
replic
capac
reovirus
rhabdovirus
vesicular
stomat
viru
vsv
synthetas
pkr
antivir
mechan
rather
gener
potenti
could
affect
wide
rang
virus
howev
ifn
induc
certain
protein
inhibit
specif
one
class
viru
exampl
ifninduc
mx
protein
block
replic
influenza
viru
probabl
inhibit
nuclear
phase
viral
transcript
mous
cell
later
cytoplasm
phase
human
cell
without
affect
replic
mani
virus
staeh
et
al
ronni
et
al
addit
sinc
ifn
impair
variou
step
viral
replic
includ
penetr
uncoat
assembl
progeni
virion
well
transcript
translat
like
sever
antivir
protein
mechan
de
maeyer
de
maeyerguignard
instanc
virus
eg
herp
viru
certain
retrovirus
appear
inhibit
rel
late
stage
viru
particl
matur
bud
aboud
hassan
cours
evolut
mani
virus
develop
countermechan
disrupt
antivir
mechan
induc
ifn
countermechan
often
point
signific
particular
antivir
protein
one
main
target
sever
differ
virus
ifninduc
pkr
action
kinas
overcom
adenoviru
epsteinbarr
viru
member
herp
viru
famili
product
small
viral
rna
molecul
vaiand
eberrna
respect
bind
pkr
block
activ
dsrna
clark
et
al
ghadg
et
al
mathew
shenk
reovirus
vaccinia
viru
member
pox
viru
famili
produc
viral
protein
ski
respect
bind
dsrna
thu
reduc
activ
pkr
sen
lengyel
interestingli
ifntreat
vsvinfect
cell
coinfect
vaccinia
viru
vsv
replic
rescu
presum
partli
inhibitori
effect
ski
pkr
whitakerdowl
youngner
vaccinia
viru
also
produc
nonfunct
protein
analog
compet
real
phosphoryl
pkr
thu
dilut
antivir
effect
activ
pkr
beatti
et
al
virus
influenza
may
activ
latent
cellular
inhibitor
pkr
activ
eg
kda
protein
lee
et
al
synthetasernas
l
system
also
subvert
exampl
emcv
picornaviru
inactiv
rnase
l
sever
cell
line
inactiv
usual
block
ifn
treatment
lengyel
herp
virus
contrast
appear
inhibit
rnase
l
activ
produc
compet
analog
cayley
et
al
virus
even
abil
block
transcript
ifninduc
gene
earli
ela
regulatori
protein
adenovirus
prevent
activ
ifn
probabl
inhibit
transcript
subunit
gutch
reich
kalvakolanu
et
nevin
case
hepat
b
virusinfect
cell
socal
virusspecifi
termin
protein
inhibit
ifninduc
gene
express
antivir
mechan
induc
ifn
mediat
enzym
eg
synthetas
picr
whose
activ
broad
implic
cell
growth
prolifer
viral
replic
may
regard
form
patholog
growth
foreign
celllik
entiti
expens
live
cell
presenc
ifn
enzym
activ
curtail
protein
synthesi
gener
viral
protein
synthesi
normal
rapid
inhibitori
effect
viral
replic
appear
dramat
slower
complex
cellular
growth
possibl
ifn
system
evolv
part
complex
interact
network
intercellular
mediat
cell
growth
prolifer
one
antivir
mechan
recent
investig
tend
support
role
ifn
regul
cell
growth
exampl
mutant
form
pkr
unabl
phosphoryl
introduc
cell
undergo
neoplast
transform
koromila
et
al
lengyel
meur
et
al
suggest
pkr
normal
act
tumorsuppressor
gene
product
therefor
one
mechan
ifn
inhibit
cell
prolifer
could
capac
induc
enhanc
expressionact
pkr
ifn
also
report
inhibit
cyclindepend
kinas
respons
phosphoryl
retinoblastoma
rb
protein
could
contribut
antiprolif
activ
kumar
atla
resnitzki
et
al
zhang
kumar
synthetasernas
l
system
may
also
antiprolif
tumor
suppressor
activ
instanc
level
two
enzym
high
growtharrest
cell
introduct
oligoadenyl
prolifer
cell
also
caus
growth
impair
sen
lengyel
lengyel
zhou
et
al
ifnstimul
increas
synthesi
pkr
synthetas
depend
ifninduc
transcript
factor
pine
et
al
william
rei
et
al
latter
short
halflif
thu
transcript
ifninduc
gene
rapidli
repress
longerlast
inhibitori
harada
et
al
overexpress
cell
becom
transform
even
low
level
constitut
product
pkr
synthetas
regul
normal
cell
growth
abrog
transform
revers
overexpress
harada
et
al
indic
view
pivot
player
growth
regulatori
tumor
suppressor
machineri
varieti
ifninduc
mechan
includ
suppress
oncogen
content
et
al
deplet
essenti
metabolit
sekar
et
al
increas
cell
rigid
e
wang
et
al
could
also
contribut
antiprolif
activ
antiprolif
effect
ifn
differ
tumor
cell
line
cultur
vitro
highli
variabl
besid
tumor
cell
line
antiprolif
activ
hematopoiet
precursor
cell
eg
myeloid
lineag
rigbi
et
al
de
maeyer
de
maeyerguignard
review
also
potent
inhibitor
angiogenesi
process
wherebi
blood
capillari
form
envascul
tissu
sidki
borden
besid
activ
intracellular
process
ifn
also
activ
intercellular
activ
especi
within
immun
system
essenti
part
host
defens
infecti
invas
diseas
thu
ifn
stimul
indirect
antivir
antitumor
mechan
main
rest
upon
cellular
differenti
induct
cytotox
activ
exampl
presenc
antigenspecif
antibodi
macrophag
effect
cellmedi
cytotox
antibodydepend
cellmedi
cytotox
adcc
enhanc
ifn
possibl
augment
immunoglobulin
g
igg
fc
receptor
fcr
express
hokland
berg
vogel
et
al
de
maeyer
de
maeyerguignard
addit
anoth
categori
leukocyt
compris
larg
granular
lymphocyt
known
natur
killer
nk
cell
activ
unknown
mechan
kill
virallyinfect
tumor
cell
target
independ
major
histocompat
complex
mhc
antigen
express
trinchieri
perussia
ragerzisman
bloom
de
maeyer
de
maeyerguignard
ifn
stimul
increas
express
class
mhc
antigen
ie
hlaa
b
c
crucial
recognit
foreign
antigen
cytotox
lymphocyt
ctl
recognit
viral
infect
cell
ctl
depend
class
mhc
antigen
present
viral
antigen
cell
membran
heron
et
al
fellou
et
al
ifn
x
sometim
observ
increas
class
ii
mhc
antigen
express
necessari
trigger
humor
cellmedi
immun
probabl
play
lesser
role
ifni
major
class
ii
mhc
antigen
induc
baldini
et
al
rhode
et
al
de
maeyer
de
maeyerguignard
biolog
activ
far
describ
see
ifn
follow
vitro
experiment
possibl
pick
choos
condit
favor
particular
outcom
eg
antivir
respons
adjust
dose
ifn
time
incub
level
viru
challeng
experi
illustr
rang
biolog
activ
ifn
defin
physiolog
role
ifn
potenti
induc
antivir
antitumor
activ
suggest
main
role
vivo
act
regul
host
defens
mechan
prevent
pathophysiolog
event
occur
investig
experiment
anim
support
likelihood
exampl
inject
mice
antiifn
antibodi
shown
increas
suscept
rang
viru
infect
virelizi
gresser
gresser
earliest
evid
antitumor
effect
came
inocul
murin
cell
mice
cell
sensit
antiprolif
action
vitro
vivo
ifn
prevent
tumor
growth
cell
howev
clone
isol
resist
antiprolif
action
lfn
occur
similar
retard
tumor
growth
upon
ifnc
treatment
observ
sensit
cell
suggest
ifn
act
indirectli
vivo
hostmedi
mechan
gresser
et
al
gresser
et
al
similar
conclus
reach
recent
use
ifnresist
bcell
lymphoma
cell
interven
year
mani
studi
conduct
confirm
ifn
act
directli
eg
human
ifna
rang
human
tumor
xenograft
nude
mice
human
activ
murin
immun
system
indirectli
review
balkwil
although
antitumor
activ
clearli
demonstr
applic
exogen
ifn
certain
endogen
produc
ifn
involv
counter
tumor
growth
howev
experiment
evid
endogen
ifn
could
play
role
host
resist
cancer
spread
obtain
treat
mice
antiifn
antibodi
condit
intraperiton
transplant
six
differ
experiment
murin
tumor
observ
gresser
ifna
inhibit
growth
hematopoiet
progenitor
cell
vitro
rigbi
et
al
also
like
occur
vivo
occurr
undesir
instanc
suppress
prolifer
bone
marrow
hematopoiet
cell
precursor
turn
advantag
protect
tumorbear
mice
cytotox
chemotherapeut
agent
stolfi
et
al
ifn
exercis
action
cell
via
ifnspecif
cell
surfac
receptor
receptor
bind
ifn
high
affin
aguet
transduc
signal
occas
ligand
ifn
bind
across
cell
membran
cytoplasm
ifncq
ifn
ifnco
share
bind
site
aguet
et
al
flore
et
al
ifni
bind
differ
site
branca
baglioni
aguet
et
al
bind
ifnc
ifn
lymphoid
cell
fibroblast
studi
extens
review
rubinstein
orchanski
branca
langer
pestka
grossberg
et
al
result
gener
demonstr
presenc
thousand
complex
highaffin
receptor
per
cell
chemic
crosslink
studi
ifn
ifn
receptorbear
cell
led
identif
variou
ifnreceptor
complex
molecular
mass
rang
kda
joshi
et
al
eid
mogensen
faltynek
et
al
raziuddin
gupta
thompson
et
al
hannigan
et
al
vanden
broeck
pfeffer
colamonici
et
al
result
suggest
either
multipl
bind
site
ifncx
ifn
ifnm
complex
multichain
receptor
colamonici
et
al
hu
et
al
although
human
cell
ifnc
ifn
ifnm
protein
compet
common
bind
site
individu
ifnc
subtyp
show
differ
level
activ
cell
streuli
et
al
week
et
al
rehberg
et
al
appear
correl
bind
behavior
cell
surfac
uzd
et
al
particular
ifn
show
much
lower
bind
human
membran
receptor
either
ifn
et
al
interestingli
differenti
bind
human
ifn
subtyp
manifest
bovin
cell
subtyp
exhibit
high
specif
activ
yonehara
et
al
shafferman
et
al
ifnm
also
activ
bovin
cell
capon
et
al
adolf
et
al
crossreact
extend
mous
cell
featur
provid
experiment
system
character
ifnreceptor
thu
somat
cell
genet
studi
human
rodent
hybrid
cell
contain
variou
combin
human
chromosom
provid
evid
presenc
human
chromosom
confer
sensit
hybrid
rodent
cell
human
ifn
ifnm
tan
et
al
slate
et
al
epstein
et
al
raziuddin
et
al
demonstr
antibodi
rais
human
chromosom
cell
surfac
protein
abl
block
bind
action
human
ifn
human
cell
indic
chromosom
contain
gene
specifi
human
ifn
cell
surfac
receptor
elucid
full
complement
compon
ifn
receptor
long
sought
one
methodolog
use
isol
receptor
cdna
involv
transfect
mous
cell
total
human
dna
select
cell
sensit
human
ifncz
sever
attempt
approach
led
success
isol
kb
edna
librari
construct
human
lymphoblastoid
daudi
cell
encod
ifncz
bind
protein
uzd
et
al
contain
amino
acid
molecular
mass
da
includ
signal
sequenc
mainli
hydrophob
amino
acid
protein
structur
typic
transmembran
glycoprotein
larg
ntermin
extracellular
domain
potenti
could
highli
glycosyl
owe
preponder
nlink
glycosyl
site
short
hydrophob
transmembran
domain
intracellular
cytoplasm
tail
figur
amino
acid
sequenc
show
littl
homolog
current
avail
sequenc
protein
includ
sequenc
human
receptor
aguet
et
al
howev
extracellular
domain
predict
show
structur
similar
latter
receptor
lesser
extent
socal
hematopoietin
receptor
supergroup
bazan
b
gene
code
put
ifncz
receptor
map
chromosom
confirm
earlier
rodent
x
human
hybrid
cell
data
tan
et
al
slate
et
al
epstein
et
raziuddin
et
al
although
clone
ifncz
receptor
could
shown
confer
sensit
human
ifn
transfect
mous
cell
uzd
et
al
cell
rel
insensit
human
ifn
human
ifn
find
togeth
antiifncz
receptor
antibodi
block
studi
colamonici
et
al
revel
et
al
uz
et
al
affin
crosslink
studi
ifn
colamonici
et
al
suggest
second
ifncz
receptor
exist
anoth
compon
requir
besid
clone
ifncz
bind
protein
complet
receptor
complex
hypothesi
support
studi
introduct
yeast
artifici
chromosom
yac
contain
segment
human
chromosom
chines
hamster
ovari
cho
cell
confer
greatli
increas
respons
well
increas
respons
ifnm
wherea
express
ifn
bind
protein
alon
confer
sensit
revel
et
al
howev
increas
respons
knock
disrupt
ifn
bind
protein
gene
yac
reconstitut
express
cdna
encod
ifn
bind
protein
cleari
et
al
suggest
cell
surfac
express
protein
requir
fulli
function
receptor
see
also
hertzog
et
al
constantinescu
et
al
second
human
receptor
probabl
addit
compon
receptor
complex
refer
clone
novick
et
al
kb
cdna
encod
protein
includ
signal
sequenc
predict
structur
transmembran
glycoprotein
ntermin
ectodomain
amino
acid
correspond
sequenc
solubl
kda
ifn
x
bind
protein
isol
urin
domain
link
transmembran
segment
amino
acid
rel
small
cytoplasm
domain
amino
acid
figur
overal
primari
sequenc
show
littl
ifna
bind
protein
bind
ifna
insensit
effect
suggest
accessori
protein
possibl
clone
ifnc
bind
protein
requir
signal
novick
et
al
constantinescu
et
al
find
antiserum
particular
monoclon
antibodi
ifncx
bind
protein
benoit
et
al
block
biolog
activ
indic
ifnhomolog
previous
clone
ifna
ifna
bind
protein
close
proxim
bind
protein
uzd
et
al
extracellular
domain
compar
related
found
novick
et
al
suggest
ifn
bind
protein
belong
socal
class
ii
cytokin
receptor
famili
et
al
two
class
cytokin
receptor
class
class
ii
propos
bazan
b
distinguish
posit
cystein
pair
extracellular
domain
latter
compris
fibronectin
type
iiilik
unit
contain
around
amino
acid
design
uzd
et
al
schemat
draw
ifna
receptor
chain
shown
figur
subsequ
found
altern
splice
receptor
gene
produc
transcript
encod
long
form
receptor
protein
contain
larger
cytoplasm
domain
amino
acid
mous
cell
transfect
cdna
encod
thu
probabl
interact
form
highaffin
ifna
receptor
complex
like
scenario
present
evid
twochain
receptor
compris
clone
ifnc
bind
protein
et
al
long
form
ifnc
bind
protein
lutfalla
et
al
bind
extent
particular
ifn
type
ifn
x
subtyp
togeth
strongli
bind
ifn
co
speci
function
transmit
signal
across
cell
membran
howev
complet
rule
cell
surfac
compon
eg
membran
glycosphingolipid
requir
fulli
function
receptor
colamonici
et
al
platania
et
al
ghislain
et
al
et
al
possibl
altern
ifn
receptor
eg
epsteinbarr
viruscompl
receptor
ifnc
receptor
blymphocyt
delcayr
et
al
vaccinia
viru
orthopoxvirus
contain
gene
b
encod
solubl
type
ifn
receptor
unlik
class
ii
cytokin
type
receptor
belong
immunoglobulin
superfamili
symon
et
al
colamonici
et
al
intracellular
domain
two
clone
ifnbind
protein
unrel
tyrosin
kinas
class
receptor
eg
epiderm
growth
factor
receptor
egfr
plateletderiv
growth
factorreceptor
pdgfr
predict
kinas
activ
sort
uzd
et
al
novick
et
al
howev
appear
cytoplasm
domain
bind
protein
associ
nonreceptor
tyrosin
kinas
janu
kinas
respect
known
involv
signal
transduct
pathway
ifna
cytokin
novick
et
al
ghislain
et
al
ihl
ihl
kerr
velasquez
et
al
current
understand
pathway
follow
bind
ifna
cognat
receptor
intracellular
domain
phosphoryl
phosphoryl
domain
act
dock
site
cytoplasm
stat
signal
transduc
activ
transcrilst
protein
statlab
stat
ihl
latter
undergo
tyrosin
phosphoryl
mediat
receptorassoci
dimer
transloc
nucleu
combin
dna
bind
protein
form
ifnstimul
gene
transcript
factor
complex
schindler
et
al
velasquez
et
al
mtiller
et
al
platania
et
al
shuai
et
al
gupta
et
al
yan
et
al
need
reciproc
activ
signal
transduct
occur
sinc
cell
mutant
lack
either
unrespons
ihl
ihl
kerr
bind
cisact
ifnstimul
respons
element
isr
present
promot
region
ifninduc
gene
initi
transcript
william
target
disrupt
stat
gene
mice
shown
stat
obligatori
role
ifncx
ifni
signal
durbin
et
al
meraz
et
al
pathway
may
receptortocel
nucleu
signal
mechan
activ
ifnstimul
cell
evid
implic
protein
kinas
c
pkc
pathway
well
reich
pfeffer
pfeffer
et
al
c
wang
et
al
howev
remain
controversi
owe
lack
specif
kinas
inhibitor
use
kessler
levi
jame
et
al
ifninduc
gene
common
regulatori
nucleotid
sequenc
ga
ggaaan
n
gaaact
flank
region
type
sequenc
resembl
vre
sequenc
ryal
et
al
present
ifn
gene
design
interferonstimul
respons
element
isr
william
resembl
isr
vre
sequenc
probabl
account
find
mani
ifninduc
gene
transcript
activ
viru
infect
dsrna
also
activ
transcript
ifn
gene
hug
et
al
wathelet
et
al
mention
previous
see
section
ifnreceptor
occup
activ
cytoplasm
complex
transloc
nucleu
bind
isr
ifninduc
gene
transcript
activ
addit
second
factor
form
complex
isr
ifnstimul
cell
singl
induc
phosphoprotein
shown
ident
pine
et
al
william
rei
et
al
role
third
transcript
factor
constitut
produc
requir
central
bp
core
isr
bind
remain
fulli
defin
kessler
et
al
number
neg
regulatori
factor
includ
harada
et
al
human
interferon
consensu
sequenc
bind
protein
icsbp
weisz
et
al
bovolenta
et
al
also
bind
isr
also
probabl
involv
regul
transcript
ifninduc
gene
clear
regul
express
ifninduc
gene
complex
mechan
control
select
express
fulli
understood
see
taylor
grossberg
review
ifninduc
protein
whose
number
probabl
exce
includ
protein
induc
earli
ifn
stimul
protein
may
produc
later
time
often
respons
action
earli
ifninduc
protein
sen
lengyel
full
set
ifninduc
protein
probabl
known
sever
identifi
character
tabl
show
incomplet
list
ifninduc
protein
togeth
like
function
protein
exclus
induc
ifni
certain
cytokin
eg
tumor
necrosi
factor
tnf
often
induc
spectra
protein
overlap
set
induc
revel
chebath
rubin
et
al
wathelet
et
al
note
ifninduc
protein
tend
also
cell
typespecif
thu
protein
list
tabl
express
cell
type
case
ifninduc
protein
complet
absent
cell
ifn
stimul
case
revel
chebath
sen
lengyel
samuel
staeh
revel
chebath
lengyel
de
maeyer
de
maeyer
guignard
heron
et
al
schwemml
staeh
ronni
et
al
revel
chebath
c
wang
et
al
kumar
atla
loeb
haa
aiidridg
et
al
fellou
et
al
sen
lengyel
sen
lengyel
bang
et
al
chebath
et
al
choubey
lengyel
lawn
et
al
constantoulaki
et
al
porter
itzhaki
hokland
berg
thoma
linch
revel
chebath
constitut
produc
synthesi
augment
ifn
gene
mous
ifn
subtyp
mous
ifn
function
mous
gene
found
locat
mous
chromosom
dandoy
et
al
dandoy
et
al
de
maeyer
de
maeyerguignard
review
gene
like
human
counterpart
intronless
compar
structur
twelv
mous
ifn
gene
pseudogen
identifi
cdna
differ
gene
clone
express
langer
pestka
de
maeyer
de
maeyerguignard
mous
ifn
subtyp
protein
contain
amino
acid
except
mous
four
cystein
posit
langer
pestka
singlecopi
mous
ifn
gene
encod
matur
mous
ifn
protein
higashi
et
al
de
maeyer
de
maeyerguignard
mous
contain
one
cystein
thu
form
intramolecular
disulfid
bond
three
potenti
nlink
glycosyl
site
heavili
glycosyl
secret
mous
fibroblast
molecular
mass
nativ
glycoprotein
approxim
kda
compar
predict
kda
nonglycosyl
counterpart
de
maeyer
de
maeyerguignard
amino
acid
sequenc
mous
relat
human
threedimcnsion
structur
mous
solv
senda
et
al
see
section
protein
shown
compris
five
shelic
fold
compact
shelic
bundl
figur
induct
transcript
mous
subtyp
gene
mous
gene
probabl
regul
transcript
factorbind
nucleotid
sequenc
present
noncod
promot
region
similar
way
human
ifn
ifn
gene
see
section
exampl
repeat
gaaarich
sequenc
present
flank
region
mous
ifncz
subtyp
gene
like
import
virusinduc
transcript
shaw
et
zwarthoff
et
al
induc
mous
ifn
synthesi
includ
number
virus
doublestrand
polynucleotid
similar
induc
human
ifnc
ifn
product
stewart
de
maeyer
de
maeyerguignard
similarli
type
ifn
produc
follow
pattern
found
among
differ
human
cell
type
fibroblast
epitheli
cell
line
produc
mainli
ifn
wherea
leukocyt
produc
mainli
subtyp
de
maeyer
de
maeyerguignard
biolog
properti
mous
ifn
similar
human
see
section
sinc
mous
human
ifn
subtyp
homolog
consider
speci
prefer
biolog
activ
ie
mous
ifncx
weakli
activ
human
cell
vice
versa
mous
also
activ
human
cell
stewart
rather
less
known
regard
receptor
mous
ifn
human
counterpart
probabl
compris
two
chain
case
human
receptor
uzd
et
al
mous
equival
receptor
chain
bind
protein
uzd
et
al
clone
uz
et
al
gene
mous
receptor
locat
mous
chromosom
cheng
et
al
mous
receptor
amino
acid
long
divid
larg
ntermin
extracellular
domain
amino
acid
short
hydrophob
transmembran
segment
amino
acid
cytoplasm
domain
amino
acid
uz
et
al
extracellular
domain
contain
eight
potenti
nlink
glycosyl
site
predict
exhibit
domain
structur
human
ifn
bind
protein
extracellular
domain
figur
uzd
et
al
mous
rceptor
compon
thereof
await
identif
character
signal
transduct
via
mous
ifn
receptor
expect
involv
stat
pathway
outlin
human
receptor
see
section
stat
genedelet
mice
overt
development
abnorm
display
complet
lack
respons
mous
ifn
durbin
et
al
meraz
et
al
consequ
stat
mice
highli
suscept
infect
virus
microbi
pathogen
stat
therefor
obligatori
mediat
signal
transduct
pathway
trigger
ifn
target
disrupt
clone
mous
receptor
gave
rise
knockout
similar
phenotyp
miiller
et
al
mice
lack
receptor
develop
normal
unabl
respond
mous
thu
unabl
cope
viral
infect
potent
antivir
activ
ifn
togeth
potenti
antitumor
action
provid
impetu
largescal
manufactur
ifn
purpos
clinic
evalu
varieti
viral
malign
diseas
earli
ifn
product
depend
pool
human
buffi
coat
leukocyt
thu
limit
quantiti
could
made
cantel
hirvonen
later
decad
human
lymphoblastoid
cell
eg
namalwa
could
grown
larg
cultur
volum
becam
avail
ifn
product
follow
clone
ifn
ifn
speci
massproduc
recombin
rdna
technolog
lead
abund
avail
certain
subtyp
eg
stabil
ifn
ser
follow
product
mean
clinic
usag
ifn
prepar
far
exce
ifn
earli
product
difficulti
latter
type
though
solv
begin
tremend
enthusiasm
manufactur
ifn
clinician
evalu
therapeut
potenti
ifn
howev
earli
clinic
trial
poorli
devis
blind
often
yield
anecdot
evid
success
mani
control
random
studi
conduct
becam
appar
ifn
gener
administ
singl
agent
benefici
treatment
major
malign
diseas
includ
major
cancer
lung
breast
colon
develop
world
initi
optim
vanish
replac
midtol
sober
realist
appreci
potenti
therapeut
valu
ofifn
number
gener
conclus
drawn
follow
ifn
lesser
extent
antitumor
activ
small
number
cancer
particularli
rel
slowgrow
welldifferenti
ii
indic
heterogen
ifn
prepar
contain
mixtur
subtyp
eg
leukocyt
ifn
lymphoblastoid
ifn
differ
clinic
effect
homogen
recombin
subtyp
ifn
prepar
iii
continu
intermitt
high
dose
appear
requir
antitumor
efficaci
iv
ifn
probabl
work
best
patient
minim
tumor
burden
balkwil
major
concern
emerg
clinic
studi
ifn
gener
consider
number
undesir
clinic
observ
sideeffect
includ
fever
chill
malais
myalgia
headach
fatigu
weight
loss
certain
case
sever
enough
treatment
halt
bottomli
toy
rohatin
et
al
goldstein
laszlo
addit
variabl
proport
patient
treat
ifn
especi
recombin
ifn
recombin
ifn
ser
develop
neutral
antibodi
ifn
speci
use
rinehart
et
al
antonelli
et
al
instanc
associ
clinic
resist
ifn
stei
et
al
oberg
et
al
freund
et
al
fossa
et
al
import
gener
unrecogn
sideeffect
ifn
treatment
possibl
induct
certain
type
autoimmun
diseas
feldmann
et
al
gutterman
probabl
mediat
via
ifninduc
upregul
mhc
antigen
express
gener
immunosuppress
respons
cancer
ifna
therapi
rare
form
bcell
leukemia
known
hairi
cell
leukemia
hcl
respons
rate
report
gutterman
baron
et
al
vedantham
et
al
hcl
patient
hairi
cell
invad
spleen
bone
marrow
diseas
take
indol
cours
shown
convincingli
ifn
therapi
continu
sever
month
lead
clearanc
hairi
cell
patient
longterm
remiss
achiev
ifn
ser
ifni
less
effect
hcl
saven
piro
ifninduc
mechan
wherebi
clearanc
hairi
cell
achiev
fulli
understood
believ
direct
action
ifn
lead
differenti
hairi
cell
nonprolifer
phenotyp
involv
vedantham
et
al
gutterman
patient
benefit
greatli
ifn
treatment
develop
neutral
antibodi
particularli
use
stei
et
al
neutral
antibodi
caus
resist
ifn
treatment
clinic
respons
rescu
switch
heterogen
prepar
eg
leukocyt
ifnc
von
wussow
et
al
howev
whole
ifn
therapi
hcl
appear
least
effect
durabl
chemotherapi
drug
pentostatin
saven
piro
therapi
also
shown
slow
progress
chronic
myelogen
leukemia
cml
baron
et
al
gutterman
malign
diseas
leukem
cell
grow
slowli
initi
chronic
benign
phase
persist
year
follow
dramat
blast
crisi
produc
rapidli
prolifer
myeloid
leukemia
cell
fatal
outcom
cml
patient
treat
ifn
chronic
phase
often
achiev
durabl
remiss
associ
elimin
leukem
cell
bear
socal
philadephia
chromosom
sometim
last
year
malign
ifna
therapi
seem
work
although
gener
lower
percentag
patient
respond
hcl
cml
includ
lowgrad
nonhodgkin
lymphoma
cutan
cell
lymphoma
carcinoid
tumor
renal
cell
carcinoma
squamou
epitheli
tumor
head
neck
multipl
myeloma
malign
melanoma
cancer
complet
respons
low
compar
partial
respons
ifn
may
help
mainten
therapi
diseas
case
eg
multipl
myeloma
mandelli
et
al
johnson
selbi
neovascular
primari
tumor
crucial
step
develop
thu
antiangiogen
activ
sidki
borden
may
therapeut
valu
certain
earli
malign
eg
primari
melanoma
gutterman
kaposi
sarcoma
often
found
aid
patient
regard
angiogen
tumor
angioprolif
diseas
may
explain
ifnc
treatment
lead
regress
lesion
patient
condit
de
wit
et
al
groopman
scadden
preclin
system
combin
oflfn
therapi
convent
chemotherapi
appear
offer
greater
chanc
produc
effect
treatment
mani
cancer
clinic
trial
strategi
produc
mostli
disappoint
result
see
wadler
schwartz
review
may
due
inabl
preclin
model
accur
predict
clinic
situat
ii
lack
understand
biochem
interact
biolog
consequ
combin
ifn
chemotox
agent
iii
failur
incorpor
inform
dose
schedul
sequenc
administr
ifn
chemotox
agent
clinic
trial
despit
proven
antivir
activ
vitro
ifn
prove
hopedfor
panacea
common
viral
infect
man
prevent
replic
common
cold
virus
rhinovirus
coronavirus
test
tube
administ
volunt
form
nasal
spray
cure
cold
establish
scott
r
al
rm
dougla
et
al
turner
et
al
ifnix
partial
effect
prevent
influenza
viru
infect
treanor
et
al
topic
applic
ifn
form
cream
ointment
herp
viru
lesion
eg
herp
zoster
chickenpox
genit
wart
condyloma
acuminatum
caus
papilloma
virus
investig
given
limit
benefici
effect
howev
administ
parenter
ie
intramuscular
intraven
inject
greater
benefici
effect
ifn
viral
caus
lesion
wart
found
although
extent
ifn
therapi
becom
treatment
choic
schneider
et
al
jm
dougla
et
al
baron
et
al
gutterman
anoth
wartlik
diseas
juvenil
laryng
papilloma
jlp
sever
obstruct
airway
young
children
caus
papilloma
viru
type
caus
genit
wart
also
found
respond
benefici
ifn
therapi
disappointingli
ifncz
therapi
appear
neither
cur
substanti
valu
adjunct
agent
longterm
manag
ofjlp
heali
et
al
probabl
success
applic
ifn
therapi
viral
diseas
treatment
chronic
activ
hepat
caus
either
hepat
b
c
virus
baron
et
al
gutterman
chronic
activ
hepat
b
patient
respond
ifn
therapi
viral
infect
marker
disappear
seroconvers
cure
follow
interest
case
hepat
b
viru
viral
activ
respons
inhibit
endogen
ifn
system
thu
administr
exogen
ifncz
constitut
replac
therapi
hepat
c
viru
infect
serotyp
viru
appar
sensit
ifn
therapi
other
prolong
treatment
may
necessari
month
prevent
relaps
occur
gutterman
ifn
ifn
shown
inhibit
human
immunodefici
replic
vitro
hartshorn
et
al
howev
vivo
littl
evid
show
ifnc
therapi
longterm
benefici
effect
asymptomat
hivlposit
individu
md
patient
friedland
et
al
lane
et
al
except
limit
regress
kaposi
sarcoma
lesion
de
wit
et
al
groopman
scadden
combin
therapi
individu
involv
ifn
antivir
drug
zidovudin
azt
also
prove
ineffect
berglund
mention
earlier
inhibit
hematopoiesi
therefor
induc
leukopenia
patient
effect
gener
thought
undesir
lead
immunosuppress
howev
prove
use
treatment
diseas
uncontrol
leukocytosi
eg
thrombocytosi
markedli
elev
platelet
number
associ
variou
myeloprolif
diseas
gissling
et
al
resist
ifn
therapi
occur
patient
neutral
antibodi
ifn
develop
success
retreat
heterogen
ifn
prepar
lymphoblastoid
ifn
report
brand
et
al
find
product
ifn
defici
multipl
sclerosi
ms
patient
neighbor
bloom
stimul
clinic
trial
evalu
ifn
ms
rather
unexpectedli
repeatedli
found
ifn
either
natur
fibroblastderiv
later
recombin
ser
inject
intrathec
subcutan
intramuscularli
patient
relapsingremit
diseas
lead
reduc
rate
exacerb
diseas
thu
possibl
clinic
benefit
patient
jacob
et
al
jacob
et
al
jacob
et
al
ifnb
multipl
sclerosi
studi
group
pati
et
al
ifn
mechan
contribut
benefici
outcom
known
probabl
immunomodulatori
action
involv
eg
suppress
growth
activ
autoreact
lymphocyt
central
nervou
system
goodkin
unclear
whether
ifnc
would
similar
effect
howev
result
ifn
treatment
encourag
far
although
followup
patient
necessari
monitor
effect
clinic
progress
ms
eber
